{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:42:29Z","timestamp":1776894149802,"version":"3.51.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014364","name":"National Children's Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014364","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10637-016-0366-3","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T19:18:14Z","timestamp":1466709494000},"page":"663-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine\u2013induced apoptosis in neuroblastoma cells"],"prefix":"10.1007","volume":"34","author":[{"given":"Jennifer C.","family":"Lennon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Butini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Campiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Clive","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela M.","family":"Zisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"issue":"23","key":"366_CR1","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362(23):2202\u20132211","journal-title":"N Engl J Med"},{"issue":"6","key":"366_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3526","volume":"13","author":"NK Cheung","year":"2013","unstructured":"Cheung NK, Dyer MA (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13(6):397\u2013411","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"366_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.biotechadv.2013.06.004","volume":"31","author":"M Saraswathy","year":"2013","unstructured":"Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31(8):1397\u20131407","journal-title":"Biotechnol Adv"},{"issue":"1","key":"366_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-3565(24)39202-X","volume":"293","author":"DM Zisterer","year":"2000","unstructured":"Zisterer DM, Campiani G, Nacci V, Williams DC (2000) Pyrrolobenzoxazepines induce apoptosis in HL-60, Jurkat and Hut-78 cells: a new class of apoptotic agents. J Pharmacol Exp Ther 293(1):48\u201359","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"366_CR5","first-page":"1357","volume":"14","author":"LM Greene","year":"2005","unstructured":"Greene LM, Fleeton M, Mulligan J, Gowda C, Sheahan BJ, Atkins GJ et al (2005) The pyrrolo-1, 5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status, and inhibits breast tumour growth in vivo. Oncol Rep 14(5):1357\u20131363","journal-title":"Oncol Rep"},{"issue":"1","key":"366_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/mol.105.021204","volume":"70","author":"JM Mulligan","year":"2006","unstructured":"Mulligan JM, Greene LM, Cloonan S, Mc Gee MM, Onnis V, Campiani G et al (2006) Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines. Mol Pharmacol 70(1):60\u201370","journal-title":"Mol Pharmacol"},{"issue":"3","key":"366_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00280-009-1200-9","volume":"66","author":"SM Nathwani","year":"2010","unstructured":"Nathwani SM, Butler S, Fayne D, McGovern N, Sarkadi B, Meegan MJ et al (2010) Novel microtubule targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug resistant (MDR) cancer cells. Cancer Chemother Pharmacol 66(3):585\u2013596","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"366_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3892\/or_00001011","volume":"24","author":"SM Nathwani","year":"2010","unstructured":"Nathwani SM, Cloonan SM, Stronach M, Campiani G, Lawler M, Williams DC et al (2010) Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells. Oncol Rep 24(6):1499\u20131507","journal-title":"Oncol Rep"},{"issue":"10","key":"366_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/sj.bjc.6605670","volume":"102","author":"SA Bright","year":"2010","unstructured":"Bright SA, McElligott AM, O\u2019Connell JW, O\u2019Connor L, Carroll P, Campiani G et al (2010) Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. Br J Cancer 102(10):1474\u20131482","journal-title":"Br J Cancer"},{"issue":"1","key":"366_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bcp.2010.02.019","volume":"80","author":"SA Bright","year":"2010","unstructured":"Bright SA, Campiani G, Deininger MW, Lawler M, Williams DC, Zisterer DM (2010) Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. Biochem Pharmacol 80(1):31\u201338","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"366_CR11","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1158\/0008-5472.CAN-09-0131","volume":"69","author":"AM McElligott","year":"2009","unstructured":"McElligott AM, Maginn EN, Greene LM, McGuckin S, Hayat A, Browne PV et al (2009) The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. Cancer Res 69(21):8366\u20138375","journal-title":"Cancer Res"},{"key":"366_CR12","doi-asserted-by":"crossref","unstructured":"Bright SA, Greene LM, Greene TF, Campiani G, Butini S, Brindisi M, Lawler M, Meegan MJ, Williams DC, Zisterer DM (2009) The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells. Biochem Pharmacol 77:310\u2013321","DOI":"10.1016\/j.bcp.2008.10.008"},{"issue":"4","key":"366_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bcp.2013.12.017","volume":"87","author":"JC Lennon","year":"2014","unstructured":"Lennon JC, Bright SA, Carroll E, Butini S, Campiani G, O\u2019Meara A et al (2014) The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells. Biochem Pharmacol 87(4):611\u2013624","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"366_CR14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/onc.2009.448","volume":"29","author":"LA Pradelli","year":"2010","unstructured":"Pradelli LA, B\u00e9n\u00e9teau M, Chauvin C, Jacquin MA, Marchetti S, Mu\u00f1oz-Pinedo C et al (2010) Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 29(11):1641\u20131652","journal-title":"Oncogene"},{"issue":"7","key":"366_CR15","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/jcp.22522","volume":"226","author":"MB Chen","year":"2011","unstructured":"Chen MB, Shen WX, Yang Y, Wu XY, Gu JH, Lu PH (2011) Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol 226(7):1915\u20131925","journal-title":"J Cell Physiol"},{"issue":"10","key":"366_CR16","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.cellsig.2013.05.026","volume":"25","author":"MB Chen","year":"2013","unstructured":"Chen MB, Zhang Y, Wei MX, Shen W, Wu XY, Yao C et al (2013) Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cell Signal 25(10):1993\u20132002","journal-title":"Cell Signal"},{"issue":"7","key":"366_CR17","doi-asserted-by":"publisher","first-page":"12778","DOI":"10.3390\/ijms150712778","volume":"15","author":"WD Wu","year":"2014","unstructured":"Wu WD, Hu ZM, Shang MJ, Zhao DJ, Zhang CW, Hong D et al (2014) Cordycepin down-regulates multiple drug resistant (MDR)\/HIF-1\u03b1 through regulating AMPK\/mTORC1 signalling in GBC-SD gallbladder cancer cells. Int J Mol Sci 15(7):12778\u201312790","journal-title":"Int J Mol Sci"},{"issue":"5","key":"366_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/labinvest.2010.36","volume":"90","author":"L Chen","year":"2010","unstructured":"Chen L, Xu B, Liu L, Luo Y, Yin J, Zhou H et al (2010) Hydrogen peroxide inhibits mTOR signaling by activation of AMPK alpha leading to apoptosis of neuronal cells. Lab Investig 90(5):762\u2013773","journal-title":"Lab Investig"},{"issue":"6","key":"366_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48(6):749\u2013762","journal-title":"Free Radic Biol Med"},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","volume":"2","author":"C Kerksick","year":"2005","unstructured":"Kerksick C, Willoughby D (2005) The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2:38\u201344","journal-title":"J Int Soc Sports Nutr"},{"issue":"3","key":"366_CR21","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1530\/ERC-12-0394","volume":"20","author":"RL Bitting","year":"2013","unstructured":"Bitting RL, Armstrong AJ (2013) Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer 20(3):R83\u2013R99","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"366_CR22","first-page":"38","volume":"27","author":"S Vinayak","year":"2013","unstructured":"Vinayak S, Carlson RW (2013) mTOR inhibitors in the treatment of breast cancer. Oncology (Williston Park) 27(1):38\u201344","journal-title":"Oncology (Williston Park)"},{"issue":"5","key":"366_CR23","first-page":"299","volume":"14","author":"D Barrett","year":"2012","unstructured":"Barrett D, Brown VI, Grupp SA, Teachey DT (2012) Targeting the PI3K\/AKT\/mTOR signaling axis in children with hematologic malignancies. Paediatr Drugs 14(5):299\u2013316","journal-title":"Paediatr Drugs"},{"issue":"4","key":"366_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","volume":"60","author":"MS Matter","year":"2014","unstructured":"Matter MS, Decaens T, Andersen JB, Thorgeirsson SS (2014) Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol 60(4):855\u2013865","journal-title":"J Hepatol"},{"issue":"20","key":"366_CR25","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1038\/sj.onc.1210938","volume":"27","author":"JI Johnsen","year":"2008","unstructured":"Johnsen JI, Segerstr\u00f6m L, Orrego A, Elfman L, Henriksson M, K\u00e5gedal B et al (2008) Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene 27(20):2910\u20132922","journal-title":"Oncogene"},{"issue":"18","key":"366_CR26","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1021\/jm960251b","volume":"39","author":"G Campiani","year":"1996","unstructured":"Campiani G, Nacci V, Fiorini I, De Filippis MP, Garofalo A, Ciani SM et al (1996) Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific \u2018peripheral-type\u2019 benzodiazepine receptor ligands. J Med Chem 39(18):3435\u20133450","journal-title":"J Med Chem"},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.juro.2007.05.120","volume":"178","author":"CR Williams","year":"2007","unstructured":"Williams CR, Tabiosa R, Linehana WM, Neckersa L (2007) Intratumor injection of the Hsp90 inhibitor 17AAG decreases tumor growth and induces apoptosis in a prostate cancer xenograft model. J Urol 178:1528\u20131532","journal-title":"J Urol"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1756-9966-28-84","volume":"28","author":"MR Shah","year":"2009","unstructured":"Shah MR, Kriedt CL, Lents NH, Hoyer MK, Jamaluddin N, Klein C et al (2009) Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer. J Exp Clin Cancer Res 28:84","journal-title":"J Exp Clin Cancer Res"},{"key":"366_CR29","first-page":"3598","volume":"63","author":"MT Beck","year":"2003","unstructured":"Beck MT, Chen NY, Franek KJ, Chen WY (2003) Experimental therapeutics prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. Cancer Res 63:3598\u20133604","journal-title":"Cancer Res"},{"key":"366_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0306-4522(02)00836-9","volume":"117","author":"M Garcia-Gil","year":"2003","unstructured":"Garcia-Gil M, Pesi R, Perna S (2003) 5\u2019-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 117:811\u2013820","journal-title":"Neuroscience"},{"key":"366_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-008-0016-3","volume":"114","author":"SM Hadad","year":"2009","unstructured":"Hadad SM, Appleyard V, Thompson AM (2009) Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat 114:391","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"366_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","volume":"162","author":"HG Kim","year":"2011","unstructured":"Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW et al (2011) Metformin inhibits P-glycoprotein expression via the NF-kB pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol 162(5):1096\u20131108","journal-title":"Br J Pharmacol"},{"issue":"2","key":"366_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214\u2013226","journal-title":"Mol Cell"},{"issue":"1","key":"366_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/JOE-11-0260","volume":"211","author":"HJ Choi","year":"2011","unstructured":"Choi HJ, Kim TY, Chung N, Yim JH, Kim WG, Kim JA et al (2011) The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside. J Endocrinol 211(1):79\u201385","journal-title":"J Endocrinol"},{"issue":"11","key":"366_CR35","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.bbadis.2012.08.006","volume":"1822","author":"K Arsikin","year":"2012","unstructured":"Arsikin K, Kravic-Stevovic T, Jovanovic M, Ristic B, Tovilovic G, Zogovic N et al (2012) Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells. Biochim Biophys Acta 1822(11):1826\u20131836","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"366_CR36","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4161\/cbt.8.16.8964","volume":"8","author":"BJ Lestini","year":"2009","unstructured":"Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B et al (2009) Mcl-1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer Biol Ther 8(16):1587\u20131595","journal-title":"Cancer Biol Ther"},{"key":"366_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13:251\u2013262","journal-title":"Nat Rev Mol Cell Biol"},{"key":"366_CR38","doi-asserted-by":"publisher","first-page":"32539","DOI":"10.1074\/jbc.M706543200","volume":"282","author":"MJ Sanders","year":"2007","unstructured":"Sanders MJ, Ali ZS, Hegarty BD, Heath R, Snowden MA, Carling D (2007) Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem 282:32539\u201332548","journal-title":"J Biol Chem"},{"issue":"18","key":"366_CR39","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.17420111","volume":"25","author":"DG Hardie","year":"2011","unstructured":"Hardie DG (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25(18):1895\u20131908","journal-title":"Genes Dev"},{"key":"366_CR40","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nrm2249","volume":"8","author":"DG Hardie","year":"2007","unstructured":"Hardie DG (2007) AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774\u2013785","journal-title":"Nat Rev Mol Cell Biol"},{"key":"366_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S et al (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18:283\u2013293","journal-title":"Mol Cell"},{"key":"366_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ncb1537","volume":"9","author":"J Liang","year":"2007","unstructured":"Liang J, Shao SH, Xu ZX et al (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9:218\u2013224","journal-title":"Nat Cell Biol"},{"key":"366_CR43","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nm1001-1111","volume":"7","author":"PM Hwang","year":"2001","unstructured":"Hwang PM, Bunz F, Yu J, Rago C et al (2001) Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 7:1111\u20131117","journal-title":"Nat Med"},{"key":"366_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97\u2013110","journal-title":"Drug Resist Updat"},{"key":"366_CR45","doi-asserted-by":"publisher","first-page":"37832","DOI":"10.1074\/jbc.M301546200","volume":"278","author":"H Pelicano","year":"2003","unstructured":"Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W et al (2003) Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278:37832\u201337839","journal-title":"J Biol Chem"},{"key":"366_CR46","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1093\/jn\/134.11.3201S","volume":"134","author":"KA Conklin","year":"2004","unstructured":"Conklin KA (2004) Free radicals: the pros and cons of antioxidants. Cancer chemotherapy and antioxidants. J Nutr 134:3201\u20133204, ISSN 0022\u20133166","journal-title":"J Nutr"},{"issue":"1","key":"366_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245\u2013313","journal-title":"Physiol Rev"},{"issue":"2","key":"366_CR48","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/ijms14023683","volume":"14","author":"R Paletta-Silva","year":"2013","unstructured":"Paletta-Silva R, Rocco-Machado N, Meyer-Fernandes JR (2013) NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity. Int J Mol Sci 14(2):3683\u20133704","journal-title":"Int J Mol Sci"},{"issue":"8","key":"366_CR49","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-06-3914","volume":"67","author":"J Alexandre","year":"2007","unstructured":"Alexandre J, Hu Y, Lu W, Pelicano H, Huang P (2007) Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 67(8):3512\u20133517","journal-title":"Cancer Res"},{"issue":"21","key":"366_CR50","doi-asserted-by":"publisher","first-page":"18383","DOI":"10.1074\/jbc.M112058200","volume":"227","author":"MM Mc Gee","year":"2002","unstructured":"Mc Gee MM, Campiani G, Ramunno A, Nacci V, Lawler M, Williams DC et al (2002) Activation of the c-Jun NH2 terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells. J Biol Chem 227(21):18383\u201318389","journal-title":"J Biol Chem"},{"key":"366_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12272-012-0415-1","volume":"4","author":"JE Han","year":"2012","unstructured":"Han JE, Choi JW (2012) Control of JNK for an activation of NADPH oxidase in LPS-stimulated BV2 microglia. Arch Pharm Res 4:709\u2013715","journal-title":"Arch Pharm Res"},{"key":"366_CR52","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1038\/cddis.2011.12","volume":"2","author":"LU Ling","year":"2011","unstructured":"Ling LU, Tan KB, Lin H, Chiu GN (2011) The role of reactive oxygen species and autophagy in safingol-induced cell death. Cell Death Dis 2:e129","journal-title":"Cell Death Dis"},{"issue":"2","key":"366_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/jpet.104.075119","volume":"312","author":"YJ Wu","year":"2005","unstructured":"Wu YJ, Muldoon LL, Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312(2):424\u2013431","journal-title":"J Pharmacol Exp Ther"},{"key":"366_CR54","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265\u20137279","journal-title":"Oncogene"},{"issue":"2","key":"366_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0960-9822(98)70037-5","volume":"8","author":"DR Alessi","year":"1998","unstructured":"Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J (1998) Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8(2):69\u201381","journal-title":"Curr Biol"},{"issue":"7","key":"366_CR56","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1158\/0008-5472.CAN-12-3767","volume":"73","author":"EE Santo","year":"2013","unstructured":"Santo EE, Stroeken P, Sluis PV, Koster J, Versteeg R, Westerhout EM (2013) FOXO3a is a major target of inactivation by PI3K\/AKT signaling in aggressive neuroblastoma. Cancer Res 73(7):2189\u20132198","journal-title":"Cancer Res"},{"key":"366_CR57","doi-asserted-by":"publisher","first-page":"41970","DOI":"10.1074\/jbc.M302403200","volume":"278","author":"S Horman","year":"2003","unstructured":"Horman S, Beauloye C, Vertommen D, Vanoverschelde JL, Hue L, Rider MH (2003) Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J Biol Chem 278:41970\u201341976","journal-title":"J Biol Chem"},{"key":"366_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0960-9822(02)01077-1","volume":"12","author":"S Horman","year":"2002","unstructured":"Horman S, Browne G, Krause U, Patel J, Vertommen D, Bertrand L et al (2002) Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 12:1419\u20131423","journal-title":"Curr Biol"},{"issue":"9","key":"366_CR59","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/1535-7163.MCT-12-1224","volume":"12","author":"G Liu","year":"2013","unstructured":"Liu G, Wang R, Wang Y, Li P, Zhao G, Zhao L et al (2013) Ethacrynic acid oxadiazole analogs induce apoptosis in malignant hematologic cells through downregulation of Mcl-1 and c-FLIP, which was attenuated by GSTP1-1. Mol Cancer Ther 12(9):1837\u20131847","journal-title":"Mol Cancer Ther"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-016-0366-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-016-0366-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-016-0366-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-016-0366-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:35:00Z","timestamp":1748990100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-016-0366-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1007\/s10637-016-0366-3","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"26 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}